Necip Sayiner Sells 1,586 Shares of Axcelis Technologies (NASDAQ:ACLS) Stock

Axcelis Technologies, Inc. (NASDAQ:ACLSGet Free Report) Director Necip Sayiner sold 1,586 shares of Axcelis Technologies stock in a transaction dated Wednesday, June 3rd. The shares were sold at an average price of $157.44, for a total value of $249,699.84. Following the completion of the sale, the director directly owned 7,112 shares in the company, valued at $1,119,713.28. This represents a 18.23% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website.

Axcelis Technologies Stock Performance

ACLS opened at $147.16 on Friday. The business’s 50-day moving average price is $134.84 and its two-hundred day moving average price is $103.37. Axcelis Technologies, Inc. has a 1 year low of $61.50 and a 1 year high of $171.61. The company has a market capitalization of $4.52 billion, a price-to-earnings ratio of 45.84, a P/E/G ratio of 11.46 and a beta of 1.91. The company has a debt-to-equity ratio of 0.04, a current ratio of 4.59 and a quick ratio of 2.99.

Axcelis Technologies (NASDAQ:ACLSGet Free Report) last released its quarterly earnings results on Thursday, May 7th. The semiconductor company reported $0.72 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.71 by $0.01. Axcelis Technologies had a return on equity of 12.19% and a net margin of 11.93%.The firm had revenue of $198.96 million for the quarter, compared to the consensus estimate of $195.03 million. During the same quarter last year, the business posted $0.88 EPS. The company’s revenue for the quarter was up 3.3% on a year-over-year basis. Axcelis Technologies has set its Q2 2026 guidance at 0.900- EPS. Equities analysts expect that Axcelis Technologies, Inc. will post 3.21 EPS for the current fiscal year.

Analyst Ratings Changes

ACLS has been the topic of several recent research reports. Zacks Research raised Axcelis Technologies from a “strong sell” rating to a “hold” rating in a research note on Monday, April 20th. B. Riley Financial raised Axcelis Technologies from a “neutral” rating to a “buy” rating and set a $150.00 price target on the stock in a research note on Monday, April 20th. Finally, Weiss Ratings downgraded Axcelis Technologies from a “hold (c)” rating to a “hold (c-)” rating in a research note on Tuesday, May 12th. Three equities research analysts have rated the stock with a Buy rating, two have assigned a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat, Axcelis Technologies has an average rating of “Hold” and an average price target of $116.25.

Check Out Our Latest Stock Analysis on ACLS

Hedge Funds Weigh In On Axcelis Technologies

Several hedge funds have recently modified their holdings of ACLS. Royal Bank of Canada grew its holdings in shares of Axcelis Technologies by 3.8% in the 1st quarter. Royal Bank of Canada now owns 117,566 shares of the semiconductor company’s stock valued at $5,838,000 after acquiring an additional 4,324 shares in the last quarter. AQR Capital Management LLC grew its holdings in shares of Axcelis Technologies by 4.9% in the 1st quarter. AQR Capital Management LLC now owns 35,717 shares of the semiconductor company’s stock valued at $1,774,000 after acquiring an additional 1,678 shares in the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. grew its holdings in shares of Axcelis Technologies by 4.6% in the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 19,396 shares of the semiconductor company’s stock valued at $963,000 after acquiring an additional 849 shares in the last quarter. Goldman Sachs Group Inc. grew its holdings in shares of Axcelis Technologies by 7.5% in the 1st quarter. Goldman Sachs Group Inc. now owns 635,393 shares of the semiconductor company’s stock valued at $31,560,000 after acquiring an additional 44,275 shares in the last quarter. Finally, UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC grew its holdings in shares of Axcelis Technologies by 1.1% in the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 78,756 shares of the semiconductor company’s stock valued at $3,912,000 after acquiring an additional 836 shares in the last quarter. Institutional investors own 89.98% of the company’s stock.

About Axcelis Technologies

(Get Free Report)

Axcelis Technologies, Inc is a leading developer and manufacturer of ion implantation and cleaning equipment used in the fabrication of semiconductor chips. The company specializes in high-current, medium-current and high-energy ion implantation systems, which are critical for introducing precisely controlled dopants into silicon wafers. Axcelis also offers plasma-based cleaning and dry strip tools that support advanced process nodes in logic, memory and power device manufacturing.

The company’s product portfolio encompasses single-wafer and multi-wafer cluster tools designed to deliver high throughput, accuracy and uniformity for semiconductor process steps.

Featured Stories

Insider Buying and Selling by Quarter for Axcelis Technologies (NASDAQ:ACLS)

Receive News & Ratings for Axcelis Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Axcelis Technologies and related companies with MarketBeat.com's FREE daily email newsletter.